CLINICAL_TRIALS
trial_result
· 2024-10-09
Clinical Trial Update: Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder [Phase 2]
Summary
Phase 2 clinical trial evaluating esketamine with dexmedetomidine sedation during pediatric head MRI in children with autism spectrum disorder; the study status…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maternal and Child Health Hospital of Hubei Province | Conditions: Autism Spectrum Disorder, Dexmedetomidine | Phase 2 | Status: COMPLETED